In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The Trump administration is poised to supercharge America’s appetite for supplements.
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...